David Roth

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Todd Rosenthal, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Roth:

Company Role Class Num Shares Value Price $ Report Date Ownership
Syros Pharmaceuticals, Inc. Chief Medical Officer Common Stock 0 $0 $0.2212 18 Nov 2024 Direct
Syros Pharmaceuticals, Inc. Chief Medical Officer Restricted Stock Units 0 $0 $2.09 31 Oct 2024 Direct

Insider Reports Filed by David Roth

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SYRS Syros Pharmaceuticals, Inc. 18 Nov 2024 1 -$2,382 4 Chief Medical Officer 20 Nov 2024, 17:00
SYRS Syros Pharmaceuticals, Inc. 31 Oct 2024 3 -$14,162 4 Chief Medical Officer 04 Nov 2024, 17:01
SYRS Syros Pharmaceuticals, Inc. 03 Apr 2024 1 -$51,732 4 Chief Medical Officer 05 Apr 2024, 16:30
SYRS Syros Pharmaceuticals, Inc. 31 Mar 2024 6 -$24,975 4 Chief Medical Officer 02 Apr 2024, 16:58
SYRS Syros Pharmaceuticals, Inc. 12 Dec 2023 1 -$31,121 4 Chief Medical Officer 14 Dec 2023, 16:24
SYRS Syros Pharmaceuticals, Inc. 06 Dec 2023 1 -$24,834 4 Chief Medical Officer 08 Dec 2023, 16:23
SYRS Syros Pharmaceuticals, Inc. 31 Oct 2023 3 -$13,988 4 Chief Medical Officer 02 Nov 2023, 16:52
SYRS Syros Pharmaceuticals, Inc. 31 Jul 2023 1 -$29,025 4 Chief Medical Officer 02 Aug 2023, 16:21
SYRS Syros Pharmaceuticals, Inc. 31 Mar 2023 3 -$1,607 4 Chief Medical Officer 04 Apr 2023, 18:56
SYRS Syros Pharmaceuticals, Inc. 16 Feb 2023 1 $0 4 Chief Medical Officer 21 Feb 2023, 15:24
SYRS Syros Pharmaceuticals, Inc. 06 Oct 2022 2 $0 4 Chief Medical Officer 11 Oct 2022, 16:38
ALLR Allarity Therapeutics, Inc. 07 Jul 2022 0 $0 3 Director 11 Jul 2022, 17:15
SYRS Syros Pharmaceuticals, Inc. 01 Apr 2022 1 -$30,555 4 Chief Medical Officer 04 Apr 2022, 17:03
SYRS Syros Pharmaceuticals, Inc. 15 Feb 2022 3 $0 4 Chief Medical Officer 17 Feb 2022, 15:10